TC Medical(SH:600763) Sou Hu Cai Jing·2025-08-08 11:58Core Viewpoint - Tongce Medical (600763) shows a slight increase in stock price and mixed capital flow, indicating potential investor interest despite some outflows from major and retail investors [1][2]. Group 1: Stock Performance - As of August 8, 2025, Tongce Medical's stock closed at 45.32 CNY, up 0.13% with a turnover rate of 2.04% and a trading volume of 91,100 lots, amounting to a transaction value of 413 million CNY [1]. - Over the past five days, the stock has experienced fluctuations in capital flow, with a net outflow of 729.48 million CNY from major funds on August 8, while retail investors saw a net inflow of 1,590.59 million CNY [1]. Group 2: Financial Metrics - Tongce Medical's total market capitalization is 20.271 billion CNY, with a net asset value of 4.574 billion CNY and a net profit of 184 million CNY [2]. - The company's first-quarter report for 2025 indicates a main revenue of 745 million CNY, a year-on-year increase of 5.11%, and a net profit increase of 6.22% to 184 million CNY [2]. - Key financial ratios include a price-to-earnings ratio of 27.55, a price-to-book ratio of 5.06, a gross margin of 44.21%, and a net margin of 29.02% [2]. Group 3: Industry Comparison - In comparison to the healthcare services industry averages, Tongce Medical ranks 8th in market capitalization, 12th in net assets, and 5th in net profit among 42 companies [2]. - The company's return on equity (ROE) stands at 4.46%, significantly higher than the industry average of 1.24%, indicating better efficiency in generating profits from equity [2]. Group 4: Analyst Ratings - In the last 90 days, three institutions have rated Tongce Medical with a "buy" recommendation, and the average target price set by analysts is 47.47 CNY [3].